Bebulin Side Effects

Generic name: factor ix complex

Medically reviewed by Drugs.com. Last updated on Apr 2, 2025.

Note: This document provides detailed information about Bebulin Side Effects associated with factor ix complex. Some dosage forms listed on this page may not apply specifically to the brand name Bebulin.

Applies to factor ix complex: intravenous powder for injection.

Get emergency medical help if you have signs of an allergic reaction: hives or rash; fast heartbeats; chest tightness, wheezing, difficult breathing; swelling of your face, lips, tongue, or throat.

Stop using this medicine and call your doctor at once if you have:

• sweating and feeling short of breath;

• a light-headed feeling, like you might pass out;

• easy bruising, increased bleeding episodes;

• bleeding from a wound or where the medicine was injected;

• signs of a blood clot in the lung--chest pain, sudden cough, wheezing, rapid breathing, coughing up blood; or

• signs of a blood clot in your leg--pain, swelling, warmth, or redness in one or both legs.

Common side effects may include:

• headache;

• flushing (warmth, redness, or tingly feeling);

• nausea, vomiting;

• fever, chills; or

• lack of energy.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.

For healthcare professionals

Applies to factor ix complex: intravenous powder for injection.

General adverse events

Adverse reactions may include headache, fever, chills, flushing, nausea, vomiting, tingling, lethargy, urticaria, and manifestations of allergic reactions.^[Ref]

Cardiovascular

• Frequency not reported: Flushing, hypotension
• Postmarketing reports: Thrombosis, deep vein thrombosis, tachycardia^[Ref]

Immunologic

• Frequency not reported: Allergic reaction
• Postmarketing reports: Hypersensitivity reaction, inhibitor antibody development, anaphylactic/anaphylactoid reaction^[Ref]

Respiratory

• Postmarketing reports: Pulmonary embolism, shortness of breath, dyspnea, bronchospasm, wheezing, cough^[Ref]

Dermatologic

• Frequency not reported: Urticaria, erythema
• Postmarketing reports: Diaphoresis, angioedema, rash, pruritus^[Ref]

Hematologic

• Postmarketing reports: Disseminated intravascular coagulation^[Ref]

Nervous system

• Frequency not reported: Headache, tingling, lethargy, dizziness
• Postmarketing reports: Thrombotic stroke^[Ref]

Gastrointestinal

• Frequency not reported: Nausea, vomiting
• Postmarketing reports: Abdominal pain^[Ref]

Other

• Frequency not reported: Fever, chills
• Postmarketing reports: Facial edema^[Ref]

Renal

• Postmarketing reports: Nephrotic syndrome (following attempted immune tolerance induction)

Local

• Postmarketing reports: Infusion site reactions, infusion site pain

See also:

Further information

Bebulin side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.

Medical Disclaimer